Search Results - "BULLERDIEK, Jorn"

Refine Results
  1. 1

    Causal discovery of gene regulation with incomplete data by Foraita, Ronja, Friemel, Juliane, Günther, Kathrin, Behrens, Thomas, Bullerdiek, Jörn, Nimzyk, Rolf, Ahrens, Wolfgang, Didelez, Vanessa

    “…Causal discovery algorithms aim to identify causal relations from observational data and have become a popular tool for analysing genetic regulatory systems…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Angiogenetic Signaling through Hypoxia: HMGB1: An Angiogenetic Switch Molecule by Schlueter, Claudia, Weber, Holger, Meyer, Britta, Rogalla, Piere, Roser, Kerstin, Hauke, Sven, Bullerdiek, Jorn

    Published in The American journal of pathology (01-04-2005)
    “…The initiation of angiogenesis, called the angiogenetic switch, is a crucial early step in tumor progression and propagation, ensuring an adequate oxygen…”
    Get full text
    Journal Article
  5. 5

    Expression of microRNAs of C19MC in Different Histological Types of Testicular Germ Cell Tumour by Flor, Inga, Spiekermann, Meike, Löning, Thomas, Dieckmann, Klaus-Peter, Belge, Gazanfer, Bullerdiek, Jörn

    Published in Cancer genomics & proteomics (01-07-2016)
    “…Testicular germ cell tumours (TGCTs) are the most common tumours in men aged from 20 to 40 years, with a steadily increasing incidence. This study aimed to…”
    Get full text
    Journal Article
  6. 6

    Patterns of Chromosomal Abnormalities that Can Improve Diagnosis of Uterine Smooth Muscle Tumors by Holzmann, Carsten, Markowski, Dominique Nadine, VON Leffern, Ingo, Löning, Thomas, Bullerdiek, Jörn

    Published in Anticancer research (01-12-2015)
    “…Compared to leiomyomas, smooth muscle tumors of uncertain malignant potential (STUMP), and leiomyosarcomas (LMS) originating from the Muellerian duct are very…”
    Get full text
    Journal Article
  7. 7

    Upregulation of HMGA2 in thyroid carcinomas: A novel molecular marker to distinguish between benign and malignant follicular neoplasias by Belge, Gazanfer, Meyer, Anke, Klemke, Markus, Burchardt, Käte, Stern, Corinna, Wosniok, Werner, Loeschke, Siegfried, Bullerdiek, Jörn

    Published in Genes chromosomes & cancer (01-01-2008)
    “…The identification of molecular markers allowing to differentiate between benign and malignant thyroid tumors remains a diagnostic challenge. Herein, we have…”
    Get full text
    Journal Article
  8. 8

    Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease by Klemke, Markus, Meyer, Anke, Nezhad, Maliheh Hashemi, Bartnitzke, Sabine, Drieschner, Norbert, Frantzen, Christiane, Schmidt, Ernst Heinrich, Belge, Gazanfer, Bullerdiek, Jörn

    Published in Genes chromosomes & cancer (01-02-2009)
    “…An overexpression of HMGA2 is supposed to be a key event in the genesis of leiomyoma with chromosomal rearrangements affecting the region 12q14‐15 targeting…”
    Get full text
    Journal Article
  9. 9

    Pretreatment oral hygiene habits and survival of head and neck squamous cell carcinoma (HNSCC) patients by Friemel, Juliane, Foraita, Ronja, Günther, Kathrin, Heibeck, Mathias, Günther, Frauke, Pflueger, Maren, Pohlabeln, Hermann, Behrens, Thomas, Bullerdiek, Jörn, Nimzyk, Rolf, Ahrens, Wolfgang

    Published in BMC oral health (11-03-2016)
    “…The survival time of patients with head and neck squamous cell carcinoma (HNSCC) is related to health behavior, such as tobacco smoking and alcohol…”
    Get full text
    Journal Article
  10. 10

    A rare coincidence of different types of driver mutations among uterine leiomyomas (UL) by Holzmann, Carsten, Markowski, Dominique Nadine, Bartnitzke, Sabine, Koczan, Dirk, Helmke, Burkhard Maria, Bullerdiek, Jörn

    Published in Molecular cytogenetics (14-10-2015)
    “…Mutations of mediator subcomplex 12 (MED12) and of high mobility group protein AT-hook 2 (HMGA2) are driver mutations in uterine leiomyomas (UL) that have not…”
    Get full text
    Journal Article
  11. 11

    TNF-α induced secretion of HMGB1 from non-immune canine mammary epithelial cells (MTH53A) by Willenbrock, Saskia, Braun, Olga, Baumgart, Judith, Lange, Sandra, Junghanss, Christian, Heisterkamp, Alexander, Nolte, Ingo, Bullerdiek, Jörn, Murua Escobar, Hugo

    Published in Cytokine (Philadelphia, Pa.) (01-02-2012)
    “…► Recombinant HMGB1 secretion by TNF-α or IFN-γ stimulation in mammary cells. ► HMGB1 release kinetics showed a clear peak release 24 h after TNF-α…”
    Get full text
    Journal Article
  12. 12

    Cytogenetically normal uterine leiomyomas without MED12-mutations - a source to identify unknown mechanisms of the development of uterine smooth muscle tumors by Holzmann, Carsten, Markowski, Dominique Nadine, Koczan, Dirk, Küpker, Wolfgang, Helmke, Burkhard Maria, Bullerdiek, Jörn

    Published in Molecular cytogenetics (29-11-2014)
    “…Recent findings on genetic changes in uterine leiomyomas suggest these benign tumors being a heterogeneous group of diseases in terms of molecular pathogenesis…”
    Get full text
    Journal Article
  13. 13

    HMGA2 expression in the PC-3 prostate cancer cell line is autonomous of growth factor stimulation by Müller, Marietta Henrike, Drieschner, Norbert, Focken, Tim, Bartnitzke, Sabine, Winter, Nina, Klemke, Markus, Bullerdiek, Jörn

    Published in Anticancer research (01-08-2013)
    “…High-mobility group AT-hook 2 (HMGA2) protein acts as an oncofoetal transcriptional regulator. In mesenchymal tissues, its expression can be induced by a…”
    Get full text
    Journal Article
  14. 14

    Identification of a gene rearranged by 2p21 aberrations in thyroid adenomas by RIPPE, Volkhard, DRIESCHNER, Norbert, MEIBOOM, Maren, ESCOBAR, Hugo Murua, BONK, Ulrich, BELGE, Gazanfer, BULLERDIEK, Jörn

    Published in Oncogene (04-09-2003)
    “…Thyroid adenomas belong to the cytogenetically best investigated human epithelial tumors. Cytogenetic studies of about 450 benign lesions allow one to…”
    Get full text
    Journal Article
  15. 15

    Genome-wide acquired uniparental disomy as well as chromosomal gains and losses in an uterine epithelioid leiomyoma by Holzmann, Carsten, Markowski, Dominique Nadine, Koczan, Dirk, Helmke, Burkhard Maria, Bullerdiek, Jörn

    Published in Molecular cytogenetics (03-03-2014)
    “…Epitheloid leiomyoma is a rare subtype of benign smooth muscle tumors. Herein, we present the results of classical cytogenetics, MED12 mutation analysis, and…”
    Get full text
    Journal Article
  16. 16

    Non-Hodgkin lymphoma expressing high levels of the danger-signalling protein HMGB1 by Meyer, Anke, Staratschek-Jox, Andrea, Springwald, Anette, Wenk, Heiner, Wolf, Jürgen, Wickenhauser, Claudia, Bullerdiek, Jörn

    Published in Leukemia & lymphoma (01-01-2008)
    “…HMGB1 is a high mobility group protein that can act either as a DNA binding protein or extracellularly as a cytokine-like danger signal. Extracellular HMGB1,…”
    Get full text
    Journal Article
  17. 17

    p14Arf acts as an antagonist of HMGA2 in senescence of mesenchymal stem cells-implications for benign tumorigenesis by Markowski, Dominique Nadine, Winter, Nina, Meyer, Frauke, von Ahsen, Inga, Wenk, Heiner, Nolte, Ingo, Bullerdiek, Jörn

    Published in Genes chromosomes & cancer (01-07-2011)
    “…HMGA2 is a major regulator of benign tumorigenesis from mesenchyme‐derived tissues and stem‐cell self‐renewal. It has been postulated that HMGA2 mediates its…”
    Get full text
    Journal Article
  18. 18

    Activation of the two microRNA clusters C19MC and miR-371-3 does not play prominent role in thyroid cancer by Rippe, Volkhard, Flor, Inga, Debler, Johannes Wolfram, Drieschner, Norbert, Rommel, Birgit, Krause, Daniel, Junker, Klaus, Bullerdiek, Jörn

    Published in Molecular cytogenetics (15-10-2012)
    “…Chromosomal rearrangements of band 19q13.4 are frequent cytogenetic alterations in benign thyroid adenomas. Apparently, these alterations lead to the…”
    Get full text
    Journal Article
  19. 19

    Quantitative PCR and Immunohistochemical Analyses of HMGB1 and RAGE Expression in Canine Disseminated Histiocytic Sarcoma (Malignant Histiocytosis) by STERENCZAK, Katharina A, KLEINSCHMIDT, Sven, WEFSTAEDT, Patrick, EBERLE, Nina, HEWICKER-TRAUTWEIN, Marion, BULLERDIEK, Jorn, NOLTE, Ingo, MURUA ESCOBAR, Hugo

    Published in Anticancer research (01-05-2011)
    “…Disorders of histiocytic origin affecting humans and dogs share various similarities. Canine disseminated histiocytic sarcoma (DHS) (formerly known as…”
    Get full text
    Journal Article
  20. 20

    Molecular topography of the MED12-deleted region in smooth muscle tumors: a possible link between non-B DNA structures and hypermutability by Markowski, Dominique Nadine, Nimzyk, Rolf, Belge, Gazanfer, Löning, Thomas, Helmke, Burkhard Maria, Bullerdiek, Jörn

    Published in Molecular cytogenetics (05-06-2013)
    “…Deletions of the gene encoding mediator subcomplex 12 (MED12) in human smooth muscle tumors rank among the most frequent genomic alterations in human tumors at…”
    Get full text
    Journal Article